| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |